![](/img/cover-not-exists.png)
A Randomized, Blinded Study of Two Doses of Novastan® (Brand of Argatroban) Versus Heparin as Adjunctive Therapy to Recombinant Tissue Plasminogen Activator (Accelerated Administration) in Acute Myocardial Infarction: Rationale and Design of the Myocardial Infarction using Novastan® and T-PA (MINT) Study
Ik-Kyung Jang, Robert P. Giugliano, Thomas J. Massey, Richard P. SchwarzVolume:
5
Year:
1998
Language:
english
Pages:
4
DOI:
10.1023/a:1008872031770
File:
PDF, 133 KB
english, 1998